On TaskTM dietary supplements contain magnesium, zinc, vitamin B-6 and vitamin C (in the tart and capsule). Suitable for ages 4 to adult, On Task is available in either a soft chew, a chewable tablet, or a capsule form. The revolutionary soft chew is the only magnesium based soft chew made in the U.S.A.! On TaskTM is made with brown rice syrup and organic evaporated cane juice. Also unique to a chocolate product, it contains no high fructose corn syrup or milk. The chewable is a sweet and sour cherry bubblegum flavored tart, the capsule is a tasteless vegetable capsule which is swallowed. The tarts and capsules are made in a FDA inspected pharmaceutical facility in the U.S.A., the soft chew is made at a healthy, well respected flavoring company also in the United States. On Task is laboratory tested and conforms to quality and purity standards established by both the U.S. Pharmacopoeia and DSHEA. On Task is stress tested to ensure potency is retained throughout its shelf life. Our products are free from gluten, corn, wheat, preservatives and artificial colors.
On TaskTM is extremely safe because it does not contain any drugs, herbs or amino acids. You will not find a comparable product. On Task is currently available online only. Order safely and securely today. FAQs answered here. Click here for information about the vitamins and minerals contained in On TaskTM. See studies on ADHD patients using these vitamins and minerals here.
On TaskTM is a 60-count bottle of chewable tarts or vegetable capsules or a 30-count bottle of soft chews for children ages 4 & up, teens, and adults. Take two chewable tablets OR capsules per day, or take one soft chew daily with a meal.
Safety and Efficacy of a Compound Natural Health Product in Children with ADHD: A Feasibility Study
A 10 week, open-label, pilot study investigating a chewable product containing zinc (15-35 mg/d), magnesium (150-350 mg/d), pyridoxine hydrochlorid (vitamin B6) (30-70 mg/d) and ascorbic acid (vitamin C) (150-250 mg/d) taken daily with meals. Mean improvements on Connors 3 (-28.9%) and SNAP-IV total (-26.4%) were clinically meaningful (p<0.001).